VeraBank N.A. Has $739,000 Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

VeraBank N.A. boosted its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 5.6% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,403 shares of the healthcare conglomerate’s stock after purchasing an additional 75 shares during the period. VeraBank N.A.’s holdings in UnitedHealth Group were worth $739,000 at the end of the most recent reporting period.

Several other large investors have also made changes to their positions in the company. Bray Capital Advisors lifted its holdings in shares of UnitedHealth Group by 0.5% during the third quarter. Bray Capital Advisors now owns 9,616 shares of the healthcare conglomerate’s stock worth $4,848,000 after buying an additional 50 shares during the last quarter. Litman Gregory Wealth Management LLC acquired a new stake in UnitedHealth Group in the 3rd quarter worth $11,680,000. Live Oak Private Wealth LLC grew its position in UnitedHealth Group by 0.8% during the third quarter. Live Oak Private Wealth LLC now owns 23,212 shares of the healthcare conglomerate’s stock worth $11,703,000 after buying an additional 179 shares in the last quarter. Hexagon Capital Partners LLC increased its position in shares of UnitedHealth Group by 3.6% during the third quarter. Hexagon Capital Partners LLC now owns 1,083 shares of the healthcare conglomerate’s stock valued at $546,000 after purchasing an additional 38 shares during the period. Finally, Cambridge Investment Research Advisors Inc. raised its position in UnitedHealth Group by 5.4% in the third quarter. Cambridge Investment Research Advisors Inc. now owns 131,333 shares of the healthcare conglomerate’s stock worth $66,217,000 after purchasing an additional 6,777 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

Shares of UNH stock traded down $0.52 during trading on Friday, reaching $492.45. 2,487,811 shares of the company’s stock traded hands, compared to its average volume of 5,130,659. The firm’s 50-day moving average is $482.32 and its 200 day moving average is $512.76. The company has a current ratio of 0.85, a quick ratio of 0.79 and a debt-to-equity ratio of 0.69. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $554.70. The company has a market capitalization of $453.09 billion, a P/E ratio of 30.10, a PEG ratio of 1.43 and a beta of 0.55.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.63 by $0.28. The company had revenue of $99.80 billion for the quarter, compared to analyst estimates of $99.23 billion. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The firm’s revenue for the quarter was up 8.6% compared to the same quarter last year. During the same period in the previous year, the company posted $6.26 EPS. Equities research analysts expect that UnitedHealth Group Incorporated will post 27.6 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were given a $1.88 dividend. The ex-dividend date of this dividend was Friday, March 8th. This represents a $7.52 dividend on an annualized basis and a dividend yield of 1.53%. UnitedHealth Group’s dividend payout ratio is currently 45.97%.

Analyst Upgrades and Downgrades

A number of brokerages have issued reports on UNH. Truist Financial restated a “buy” rating and issued a $600.00 target price on shares of UnitedHealth Group in a research note on Wednesday, April 17th. Morgan Stanley reduced their price target on shares of UnitedHealth Group from $618.00 to $584.00 and set an “overweight” rating on the stock in a research report on Friday, April 5th. StockNews.com downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Thursday, April 18th. Deutsche Bank Aktiengesellschaft upped their price objective on UnitedHealth Group from $545.00 to $562.00 and gave the stock a “buy” rating in a report on Friday, April 19th. Finally, Oppenheimer reiterated an “outperform” rating and issued a $610.00 price target on shares of UnitedHealth Group in a research report on Wednesday, January 17th. Four equities research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $570.05.

Insider Buying and Selling

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of UnitedHealth Group stock in a transaction that occurred on Friday, March 8th. The shares were sold at an average price of $483.48, for a total value of $597,581.28. Following the completion of the sale, the executive vice president now owns 9,364 shares of the company’s stock, valued at approximately $4,527,306.72. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. In other news, CAO Thomas E. Roos sold 858 shares of the stock in a transaction that occurred on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the transaction, the chief accounting officer now owns 32,289 shares in the company, valued at approximately $16,977,233.31. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Erin Mcsweeney sold 1,236 shares of the company’s stock in a transaction that occurred on Friday, March 8th. The shares were sold at an average price of $483.48, for a total transaction of $597,581.28. Following the sale, the executive vice president now directly owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The disclosure for this sale can be found here. 0.35% of the stock is owned by insiders.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.